1. Home
  2. CGTX vs BEDU Comparison

CGTX vs BEDU Comparison

Compare CGTX & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • BEDU
  • Stock Information
  • Founded
  • CGTX 2007
  • BEDU 1994
  • Country
  • CGTX United States
  • BEDU United Kingdom
  • Employees
  • CGTX N/A
  • BEDU N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • BEDU Other Consumer Services
  • Sector
  • CGTX Health Care
  • BEDU Real Estate
  • Exchange
  • CGTX Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • CGTX 53.4M
  • BEDU 54.3M
  • IPO Year
  • CGTX 2021
  • BEDU 2017
  • Fundamental
  • Price
  • CGTX $2.41
  • BEDU $1.70
  • Analyst Decision
  • CGTX Strong Buy
  • BEDU
  • Analyst Count
  • CGTX 3
  • BEDU 0
  • Target Price
  • CGTX $2.83
  • BEDU N/A
  • AVG Volume (30 Days)
  • CGTX 12.4M
  • BEDU 1.4K
  • Earning Date
  • CGTX 08-07-2025
  • BEDU 11-25-2025
  • Dividend Yield
  • CGTX N/A
  • BEDU N/A
  • EPS Growth
  • CGTX N/A
  • BEDU N/A
  • EPS
  • CGTX N/A
  • BEDU N/A
  • Revenue
  • CGTX N/A
  • BEDU $224,321,752.00
  • Revenue This Year
  • CGTX N/A
  • BEDU N/A
  • Revenue Next Year
  • CGTX N/A
  • BEDU N/A
  • P/E Ratio
  • CGTX N/A
  • BEDU N/A
  • Revenue Growth
  • CGTX N/A
  • BEDU N/A
  • 52 Week Low
  • CGTX $0.22
  • BEDU $1.35
  • 52 Week High
  • CGTX $3.83
  • BEDU $2.19
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 61.15
  • BEDU 44.10
  • Support Level
  • CGTX $2.26
  • BEDU $1.71
  • Resistance Level
  • CGTX $2.67
  • BEDU $1.73
  • Average True Range (ATR)
  • CGTX 0.40
  • BEDU 0.04
  • MACD
  • CGTX -0.03
  • BEDU -0.01
  • Stochastic Oscillator
  • CGTX 42.08
  • BEDU 9.68

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: